Everolimus Tablet — FDA Drug Shortage

To Be Discontinued — Teva Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Everolimus Tablet (tablet) from Teva Pharmaceuticals USA, Inc. with status To Be Discontinued. The shortage was first posted on Mar 2, 2026.

Shortage details

Status
To Be Discontinued
Company
Teva Pharmaceuticals USA, Inc.
Package NDC
0093-7769-24
Dosage Form
Tablet
Presentation
Everolimus, Tablet, 10 mg (NDC 0093-7769-24)
Initial Posting
Mar 2, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.